Geraldine Rauch

Publication Activity (10 Years)

Years Active: 2015-2024
Publications (10 Years): 26

Top Topics

Silver Nanoparticles

Top Venues

Statistics in medicine

BMC medical research methodology

Journal of biopharmaceutical statistics

Pharmaceutical statistics

This page only lists publications with an associated author ORCID identifier.

Publications

Michaela Maria Freitag, Xieran Li, Geraldine Rauch
Optimal futility stopping boundaries for binary endpoints. BMC medical research methodology 24 (1) (2024)
Michaela Maria Freitag, Xieran Li, Geraldine Rauch
Optimal futility stopping boundaries for binary endpoints. BMC medical research methodology 24 (1) (2024)
Jan Meis, Maximilian Pilz, Björn Bokelmann, Carolin Herrmann, Geraldine Rauch, Meinhard Kieser
Point estimation, confidence intervals, and P-values for optimal adaptive two-stage designs with normal endpoints. Statistics in medicine 43 (8) (2024)
Michaela Maria Freitag, Xieran Li, Geraldine Rauch
Optimal futility stopping boundaries for binary endpoints. BMC medical research methodology 24 (1) (2024)
Jan Meis, Maximilian Pilz, Björn Bokelmann, Carolin Herrmann, Geraldine Rauch, Meinhard Kieser
Point estimation, confidence intervals, and P-values for optimal adaptive two-stage designs with normal endpoints. Statistics in medicine (2024)
Michaela Maria Freitag, Xieran Li, Geraldine Rauch
Optimal futility stopping boundaries for binary endpoints. BMC medical research methodology 24 (1) (2024)
Jan Meis, Maximilian Pilz, Björn Bokelmann, Carolin Herrmann, Geraldine Rauch, Meinhard Kieser
Point estimation, confidence intervals, and P-values for optimal adaptive two-stage designs with normal endpoints. Statistics in medicine 43 (8) (2024)
Jan Meis, Maximilian Pilz, Björn Bokelmann, Carolin Herrmann, Geraldine Rauch, Meinhard Kieser
Point estimation, confidence intervals, and P-values for optimal adaptive two-stage designs with normal endpoints. Statistics in medicine 43 (8) (2024)
Joachim E Weber, Michael Ahmadi, Leif-Hendrik Boldt, Kai Uwe Eckardt, Frank Edelmann, Holger Gerhardt, Ulrike Grittner, Kathrin Haubold, Norbert Hübner, Ulf Landmesser, David Manuel Leistner, Knut Mai, Dominik N Muller, Christian H Nolte, Burkert Pieske, Sophie Käthe Piper, Simrit Rattan, Geraldine Rauch, Sein Schmidt, Kai M Schmidt-Ott, Katharina Schönrath, Jeanette Schulz-Menger, Oliver Schweizerhof, Bob Siegerink, Joachim Spranger, Ramachandran S Vasan, Martin Witzenrath, Matthias Endres, Tobias Pischon
Protocol of the Berlin Long-term Observation of Vascular Events (BeLOVE): a prospective cohort study with deep phenotyping and long-term follow up of cardiovascular high-risk patients. BMJ open 13 (10) (2023)
Jan Meis, Maximilian Pilz, Carolin Herrmann, Björn Bokelmann, Geraldine Rauch, Meinhard Kieser
Optimization of the two-stage group sequential three-arm gold-standard design for non-inferiority trials. Statistics in medicine (2022)
Meinhard Kieser, Geraldine Rauch, Maximilian Pilz
Two-stage designs with small sample sizes. Journal of biopharmaceutical statistics (2022)
Jan Meis, Maximilian Pilz, Carolin Herrmann, Björn Bokelmann, Geraldine Rauch, Meinhard Kieser
Optimization of the two-stage group sequential three-arm gold-standard design for non-inferiority trials. Statistics in medicine 42 (4) (2022)
Maximilian Pilz, Carolin Herrmann, Geraldine Rauch, Meinhard Kieser
Optimal unplanned design modification in adaptive two-stage trials. Pharmaceutical statistics 21 (6) (2022)
Austin G Kulasekararaj, Axel Glasmacher, Peng Liu, Jeffrey Szer, David Araten, Geraldine Rauch, Chad Gwaltney, J Rafael Sierra, Jong Wook Lee
Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria. European journal of haematology 108 (5) (2022)
Jan Meis, Maximilian Pilz, Carolin Herrmann, Björn Bokelmann, Geraldine Rauch, Meinhard Kieser
Optimization of the two-stage group sequential three-arm gold-standard design for non-inferiority trials. Statistics in medicine 42 (4) (2022)
Dario Zocholl, Manuel Wiesenfarth, Geraldine Rauch, Dominik T Schneider
On the feasibility of pediatric dose-finding trials in small samples with information from a preceding trial in adults. Journal of biopharmaceutical statistics 32 (5) (2021)
Carolin Herrmann, Corinna Kluge, Maximilian Pilz, Meinhard Kieser, Geraldine Rauch
Improving sample size recalculation in adaptive clinical trials by resampling. Pharmaceutical statistics 20 (6) (2021)
Maximilian Pilz, Kevin Kunzmann, Carolin Herrmann, Geraldine Rauch, Meinhard Kieser
Optimal planning of adaptive two-stage designs. Statistics in medicine 40 (13) (2021)
Geraldine Rauch, Lorena Hafermann, Ulrich Robert Mansmann, Iris Pigeot
Comprehensive survey among statistical members of medical ethics committees in Germany on their personal impression of completeness and correctness of biostatistical aspects of submitted study protocols. BMJ open 10 (2) (2020)
Carolin Herrmann, Maximilian Pilz, Meinhard Kieser, Geraldine Rauch
A new conditional performance score for the evaluation of adaptive group sequential designs with sample size recalculation. Statistics in medicine 39 (15) (2020)
Paul Bach, Christine Wallisch, Nadja Klein, Lorena Hafermann, Willi Sauerbrei, Ewout W Steyerberg, Georg Heinze, Geraldine Rauch, null null
Systematic review of education and practical guidance on regression modeling for medical researchers who lack a strong statistical background: Study protocol. PloS one 15 (12) (2020)
Christine Schilhart-Wallisch, Christine Wallisch, Geraldine Rauch, Riccardo de Bin, Georg Heinze
Selection of variables for multivariable models: Opportunities and limitations in quantifying model stability by resampling. Statistics in medicine 40 (2) (2020)
Maximilian Pilz, Kevin Kunzmann, Carolin Herrmann, Geraldine Rauch, Meinhard Kieser
A variational approach to optimal two-stage designs. Statistics in medicine 38 (21) (2019)
Geraldine Rauch, Meinhard Kieser, Harald Binder, Antoni Bayes-Genis, Antje Jahn-Eimermacher
Time-to-first-event versus recurrent-event analysis: points to consider for selecting a meaningful analysis strategy in clinical trials with composite endpoints. Clinical research in cardiology : official journal of the German Cardiac Society 107 (5) (2018)
Antonia Zapf, Marianne Huebner, Geraldine Rauch, Meinhard Kieser
What makes a biostatistician? Statistics in medicine 38 (4) (2018)
Geraldine Rauch, Kevin Kunzmann, Meinhard Kieser, Karl Wegscheider, Jochem König, Christine Eulenburg
A weighted combined effect measure for the analysis of a composite time-to-first-event endpoint with components of different clinical relevance. Statistics in medicine 37 (5) (2017)
Meinhard Kieser, Geraldine Rauch
Two-stage designs for cross-over bioequivalence trials. Statistics in medicine 34 (16) (2015)